Churchill Capital Corp VII
CVII

Delisted

CVII was delisted on the 20th of August, 2024.

Back to rankings

About: Churchill Capital Corp VII is a blank check company.

Employees: 2

Financials Blank Checks

Financial journalist opinion

Churchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business Combination

Churchill Announces Redemption of Public Shares NEW YORK and ALTRINCHAM, England , Aug. 18, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill") (Nasdaq: CVII), a publicly-traded special purpose acquisition company, and CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, today announced that they have mutually agreed to terminate their previously announced merger agreement (the "Merger Agreement") due to IPO market conditions, effective today. "While market conditions are not favorable today for the public listing of CorpAcq through our proposed merger, we continue to believe in the strong fundamentals and growth prospects of the Company," said Michael S.

Churchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business Combination

Redemption Deadline for Churchill VII stockholders extended until August 9, 2024

Stockholders may elect to redeem shares of Class A Common Stock until 5:00 pm Eastern Time, August 9, 2024 NEW YORK , Aug. 5, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that the deadline for Churchill VII stockholders to elect redemption of their shares of class A common stock of Churchill VII ("Class A Common Stock") in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the "Business Combination") is extended until 5:00 P.M., Eastern Time on August 9, 2024.

Redemption Deadline for Churchill VII stockholders extended until August 9, 2024

CorpAcq and Churchill Capital Corp VII Provide an Update on Proposed Financing to Support Business Combination

Expected Financing Would De-Risk Closing of Business Combination and is Anticipated to Support CorpAcq's Future Growth NEW YORK and ALTRINCHAM, England , Aug. 2, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill Capital Corp VII ("Churchill VII") (NASDAQ: CVII), a special purpose acquisition company, today provided an update on planned equity or equity-linked financing in support of the previously announced business combination (the "Business Combination") between CorpAcq, CorpAcq Group Plc, a public limited company incorporated under the laws of England and Wales and an affiliate of CorpAcq ("CorpAcq Group Plc"), and Churchill VII. Any commitments with respect to such financing would be announced in advance of closing.

CorpAcq and Churchill Capital Corp VII Provide an Update on Proposed Financing to Support Business Combination

/C O R R E C T I O N -- Churchill Capital Corp VII/

In the news release, CorpAcq Schedules Business Update Call, issued 29-Jul-2024 by Churchill Capital Corp VII over PR Newswire, we are advised by the company that the release has been updated. The complete, corrected release follows: CorpAcq Schedules Business Update Call Call scheduled for 11am ET on Monday, July 29, 2024 ALTRINCHAM, England and NEW YORK , July 29, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII) today announced that CorpAcq will host a webcast and conference call to provide a business update at 11 AM ET on Monday, July 29, 2024.

/C O R R E C T I O N -- Churchill Capital Corp VII/

Special Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment to be Adjourned and Reconvened for August 12, 2024

Redemption deadline for stockholders moved to August 8, 2024 NEW YORK , July 18, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it intends to adjourn each of the special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") and the meeting of Churchill VII warrant holders (the "Warrant Holder Meeting"), which are currently scheduled for July 25, 2024, to be held in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the "Business Combination"). The Stockholder Special Meeting will reconvene on August 12, 2024 at 10:00 A.M.

Special Meeting of Churchill VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment to be Adjourned and Reconvened for August 12, 2024

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024

Board of Directors Recommends Stockholders and Public Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England , June 20, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders (the "Stockholder Special Meeting") to be held in connection with the proposed business combination (the "Business Combination") between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII and a meeting of Churchill VII public warrant holders (the "Warrant Holder Meeting"), each for July 25, 2024. Churchill VII stockholders and public warrant holders of record as of the close of business on June 18, 2024 (the "Record Date") will receive the definitive proxy statement/prospectus, once available (the "Proxy Statement") relating to the offer of the securities to be issued by CorpAcq Group Plc to Churchill VII's stockholders and public warrant holders in connection with the completion of the Business Combination by mail and are entitled to vote at the Stockholder Special Meeting and/or Warrant Holder Meeting, respectively.

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Public Warrant Holder Meeting to Approve Warrant Amendment Scheduled for July 25, 2024

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024

Board of Directors Recommends Stockholders and Warrant Holders Vote "FOR" All Proposals NEW YORK and ALTRINCHAM, England , March 22, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (Nasdaq: CVII), a special purpose acquisition company, announced today that it has scheduled a special meeting of Churchill VII stockholders and a meeting of Churchill VII warrant holders for May 21, 2024 in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill VII (the "Business Combination"). The Business Combination continues to progress and is expected to be completed in the first half of 2024.

Special Meeting of Churchill Capital Corp VII Stockholders to Approve Business Combination with CorpAcq and Warrant Holder Meeting to Approve Warrant Amendment Scheduled for May 21, 2024

Churchill Capital Corp VII Announces Stockholder Approval of Extension and Final Redemption Numbers

In Excess of $605 Million Remains in Churchill VII's Trust Account after Stockholder Redemptions relating to the Extension NEW YORK , Feb. 12, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ: CVII) announced today that in a special meeting of its stockholders ("Special Meeting"), Churchill VII's stockholders voted to approve a proposal to amend Churchill VII's certificate of incorporation and extend the date by which Churchill VII is required to consummate its initial business combination (the "Business Combination") with CorpAcq Holdings Limited ("CorpAcq") from February 17, 2024 to August 17, 2024 (or such earlier date as determined by the board of directors of Churchill VII). All other proposals were also approved with overwhelming support from Churchill VII's stockholders.

Churchill Capital Corp VII Announces Stockholder Approval of Extension and Final Redemption Numbers

Churchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor Contribution

Special meeting of stockholders of Churchill VII scheduled for February 8, 2024 to extend date by which Churchill VII must consummate its business combination with CorpAcq Holdings Limited NEW YORK , Jan. 30, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") announced today actions being undertaken in advance of a special meeting of its stockholders (the "Special Meeting") on February 8, 2024, at which Churchill VII's stockholders will be asked to vote on, among other things, a proposal to amend Churchill VII's amended and restated certificate of incorporation to extend the date by which Churchill VII has to consummate its business combination with CorpAcq Holdings Limited ("CorpAcq") from February 17, 2024 to August 17, 2024 or such earlier date as determined by the Churchill VII board of directors (the "Board") (the "Extension Amendment Proposal"). Churchill VII Sponsor Seeking Extension to Pursue a Business Combination with CorpAcq Holdings Limited As previously disclosed, on August 1, 2023, Churchill VII entered into a definitive agreement for a business combination (and together with the transactions contemplated thereby, the "Transactions") with CorpAcq, a corporate compounder with a proven track record of acquiring and supporting founder-led businesses.

Churchill Capital Corp VII Announces Continuation of $1,000,000 Monthly Sponsor Contribution

Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq

NEW YORK , Jan. 23, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NYSE: CVII), a special purpose acquisition company, announced today that it plans to transfer the listing of its shares of Class A common stock, public warrants and public units from the New York Stock Exchange ("NYSE") to Nasdaq Global Market ("Nasdaq"). Churchill VII expects that listing and trading of its securities on the NYSE will end at market close on February 2, 2024, and expects to commence trading as a Nasdaq-listed company upon market open on February 5, 2024.

Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq

See News Rankings

Charts implemented using Lightweight Charts™